Login to Your Account

Washington Roundup

FDA Waves Safety Flag as Arcalyst Heads to Adcomm

By Mari Serebrov
Washington Editor

Monday, May 7, 2012

WASHINGTON – Regeneron Pharmaceuticals Inc. is hoping Arcalyst can do what another IL-1 blocker couldn't do last year – wow the Arthritis Advisory Committee (AAC).

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription